Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Aren’t Crazy About Vector Group Ltd (VGR) Anymore

After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms’ equity portfolios as of September 30. The results of that effort will be put on display in this article, as we share valuable insight into the smart money sentiment towards Vector Group Ltd (NYSE:VGR).

Vector Group Ltd (NYSE:VGR) shareholders have witnessed a decrease in support from the world’s most elite money managers recently. VGR was in 17 hedge funds’ portfolios at the end of September. There were 19 hedge funds in our database with VGR positions at the end of the previous quarter. At the end of this article we will also compare VGR to other stocks including DCP Midstream Partners, LP (NYSE:DPM), Houghton Mifflin Harcourt Co (NASDAQ:HMHC), and Bruker Corporation (NASDAQ:BRKR) to get a better sense of its popularity.

Follow Vector Group Ltd (NYSE:VGR)
Trade (NYSE:VGR) Now!

In the eyes of most investors, hedge funds are perceived as unimportant, old investment vehicles of yesteryear. While there are more than an 8000 funds in operation today, Our researchers hone in on the moguls of this club, approximately 700 funds. It is estimated that this group of investors manage most of the smart money’s total asset base, and by tailing their best stock picks, Insider Monkey has figured out many investment strategies that have historically beaten the S&P 500 index. Insider Monkey’s small-cap hedge fund strategy surpassed the S&P 500 index by 12 percentage points per year for a decade in their back tests.

With all of this in mind, let’s take a glance at the key action surrounding Vector Group Ltd (NYSE:VGR).

What have hedge funds been doing with Vector Group Ltd (NYSE:VGR)?

At the end of the third quarter, a total of 17 of the hedge funds tracked by Insider Monkey were long this stock, a drop of 11% from one quarter earlier. With hedgies’ positions undergoing their usual ebb and flow, there exists a few key hedge fund managers who were boosting their stakes considerably (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Jim Simons’s Renaissance Technologies has the largest position in Vector Group Ltd (NYSE:VGR), worth close to $130.8 million, amounting to 0.3% of its total 13F portfolio. On Renaissance Technologies’s heels is Blue Mountain Capital, managed by Andrew Feldstein and Stephen Siderow, which holds a $29.4 million position; 0.5% of its 13F portfolio is allocated to the stock. Remaining hedge funds and institutional investors that hold long positions consist of Israel Englander’s Millennium Management, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital and John Overdeck and David Siegel’s Two Sigma Advisors.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.